Phase 2 Interstitial Lung Disease Trial, Not Yet Recruiting (NCT07178184)

Phase 2 Interstitial Lung Disease Trial, Not Yet Recruiting NCT07178184 Sponsor: Chinese University of Hong Kong Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07178184 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 20 and 85 years old
You have been officially diagnosed with pneumoconiosis (a lung disease caused by dust) confirmed by the Pneumoconiosis Compensation Fund Board
You are willing to have blood tests, fill in questionnaires, and take medication as scheduled
You are willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

You have been assessed by a Chinese medicine practitioner as having certain patterns such as "dampness," "lung deficiency and coldness," or "Yang deficiency" according to Chinese medicine theory (confirm with trial site)
You have been regularly taking Chinese medicine in the past 2 weeks
You have other lung scarring diseases (beyond pneumoconiosis) or an existing heart condition
You have had any cancer diagnosis within the past 5 years
You have a history of serious illnesses such as severe kidney or liver problems, autoimmune disease, thyroid disease, Hodgkin's disease, lymphoma, or leukemia
You have been diagnosed with a significant cognitive (thinking/memory) or mental health disorder
You are currently pregnant or breastfeeding
You are known to be allergic to the medication used in this study

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07178184

Sponsor: Chinese University of Hong Kong

Phase: Phase 2

Status: Not Yet Recruiting

Condition: Interstitial Lung Disease

More information: https://clinicaltrials.gov/study/NCT07178184

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 20 and 85 years old
You have been officially diagnosed with pneumoconiosis (a lung disease caused by dust) confirmed by the Pneumoconiosis Compensation Fund Board
You are willing to have blood tests, fill in questionnaires, and take medication as scheduled
You are willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

You have been assessed by a Chinese medicine practitioner as having certain patterns such as "dampness," "lung deficiency and coldness," or "Yang deficiency" according to Chinese medicine theory (confirm with trial site)
You have been regularly taking Chinese medicine in the past 2 weeks
You have other lung scarring diseases (beyond pneumoconiosis) or an existing heart condition
You have had any cancer diagnosis within the past 5 years
You have a history of serious illnesses such as severe kidney or liver problems, autoimmune disease, thyroid disease, Hodgkin's disease, lymphoma, or leukemia
You have been diagnosed with a significant cognitive (thinking/memory) or mental health disorder
You are currently pregnant or breastfeeding
You are known to be allergic to the medication used in this study

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Phase 2

Sponsor

Chinese University of Hong Kong

Registry

ClinicalTrials.gov

Start date

1 November 2025

Est. completion

31 December 2026

Primary endpoints

Change of 6-minute Walk Test (6MWT) at weeks 4, 8, 12, 16 and 20.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov